HKSE - Delayed Quote HKD
Zai Lab Limited (9688.HK)
24.400
+1.600
+(7.02%)
At close: 4:08:10 PM GMT+8
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 14.6M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Du (Samantha Ying) Chief Executive Officer | Sale at price 0.43 per share. | Direct | 12,539 | Apr 4, 2025 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Apr 3, 2025 |
Du (Samantha Ying) Chief Executive Officer | Sale at price 0.46 per share. | Direct | 26,786 | Apr 2, 2025 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Apr 1, 2025 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Mar 17, 2025 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Mar 14, 2025 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Mar 5, 2025 |
Du (Samantha Ying) Chief Executive Officer | Sale at price 0.46 per share. | Direct | 212,183 | Mar 5, 2025 |
Gaynor (Richard Brian M.D.) Independent Non-Executive Director | Sale at price 3.51 per share. | Direct | 87,675 | Mar 5, 2025 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Mar 4, 2025 |
Du (Samantha Ying) Chief Executive Officer | Sale at price 0.43 per share. | Direct | 215,400 | Mar 4, 2025 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Mar 3, 2025 |
Du (Samantha Ying) Chief Executive Officer | Sale at price 0.42 per share. | Direct | 208,550 | Mar 3, 2025 |
Du (Samantha Ying) Chief Executive Officer | Conversion at price 0.44 per share. | Direct | 221,550 | Feb 28, 2025 |
Du (Samantha Ying) Chief Executive Officer | Sale at price 0.44 per share. | Direct | 221,550 | Feb 28, 2025 |
Lis (William David) Independent Non-Executive Director | Sale at price 0.42 per share. | Direct | 63,600 | Feb 28, 2025 |
Gaynor (Richard Brian M.D.) Independent Non-Executive Director | Sale at price 1.95 per share. | Direct | 48,750 | Sep 3, 2024 |
Chen (Kaixian) Independent Non-Executive Director | Sale at price 1.72 per share. | Direct | 133,455 | Jul 1, 2024 |
Du (Samantha Ying) Chief Executive Officer | Sale at price 1.75 per share. | Direct | 122,573 | Jul 1, 2024 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Jun 29, 2024 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Jun 26, 2024 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Jun 26, 2024 |
Du (Samantha Ying) Chief Executive Officer | Sale at price 1.62 per share. | Direct | 93,465 | Apr 2, 2024 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Apr 1, 2024 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Mar 15, 2024 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Mar 15, 2024 |
Du (Samantha Ying) Chief Executive Officer | Sale at price 2.61 per share. | Direct | 218,902 | Jan 3, 2024 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Jan 1, 2024 |
Du (Samantha Ying) Chief Executive Officer | -- | Direct | -- | Jun 23, 2023 |
Du (Samantha Ying) Chief Executive Officer | Sale at price 2.53 per share. | Direct | 585,391 | Jun 23, 2023 |
Related Tickers
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
300.000
+5.12%
1801.HK INNOVENT BIO
52.450
+11.01%
2563.HK Beijing Biostar Pharms Co Ltd
4.410
-17.42%
49BA.BE BeiGene Ltd
218.00
+6.86%
49B.F BeiGene, Ltd.
16.29
+6.19%
2105.HK Laekna, Inc.
14.500
+26.53%
IMM.AX Immutep Limited
0.2450
+4.26%
3759.HK Pharmaron Beijing Co., Ltd.
12.800
+3.73%
2616.HK CStone Pharmaceuticals
2.760
+9.96%
2142.HK HBM Holdings Limited
8.110
+12.95%